NCT06704360

Brief Summary

This is a single-blind randomized controlled trial to evaluate the efficacy and safety of immersive virtual reality for post-stroke cognitive impairment.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable stroke

Timeline
Completed

Started Dec 2024

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 21, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 26, 2024

Completed
5 days until next milestone

Study Start

First participant enrolled

December 1, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

November 26, 2024

Status Verified

November 1, 2024

Enrollment Period

11 months

First QC Date

November 21, 2024

Last Update Submit

November 23, 2024

Conditions

Keywords

strokevirtual realityfNIRScognitive impairment

Outcome Measures

Primary Outcomes (3)

  • Mental State Examination Scale (MMSE)

    Global cognitive function assessment. Easy to use and one of the most used scales to screen person with cognitive impairment in the world. The minimum and maximum values range from 0 to 30. Higher score means better cognition level.

    1. finished in 3 days before training. 2. finished 3 days after 30-days training

  • Montreal Cognitive Assessment (MoCA)

    one of the most used scales to assess cognition and screen person with cognitive impairment in the world. The minimum and maximum values range from 0 to 30. Higher score means better cognition level.

    1. finished in 3 days before training. 2. finished 3 days after 30-days training

  • Brain functional activation (fNIRS)

    Brain functional activation of each patient during the cognitive task (Stroop task, 1-back task and verbal fluency test) will be evaluated using functional near-infrared spectroscopy (fNIRS).

    1. finished in 3 days before training. 2. finished 3 days after 30-days training

Study Arms (2)

VR group (virtual reality cognitive training group)

EXPERIMENTAL

Immersive VR cognitive training with suitable training intensity.

Device: immersive VR pathfinding training

OT group (occupational therapy group)

ACTIVE COMPARATOR

Conventional cognitive training (occupational therapy) with suitable training intensity.

Other: Occupational therapy

Interventions

Pathfinding training with immersive VR.

VR group (virtual reality cognitive training group)

Only receive conventional cognitive training group

OT group (occupational therapy group)

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of stroke by neuroimaging (CT or MRI) assessment
  • years old
  • Be able to follow instructions to complete the test
  • Can tolerate the rehabilitation training of this experiment
  • First stroke
  • Patients who signed informed consent

You may not qualify if:

  • The test could not be tolerated due to organic disease
  • There is a serious mental illness resulting in inability to cooperate with or tolerate this test
  • is participating in another clinical trial involving an investigational drug or physical therapy
  • Patients who have not signed informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

StrokeCognitive Dysfunction

Interventions

Occupational Therapy

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesCognition DisordersNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

RehabilitationAftercareContinuity of Patient CarePatient CareTherapeutics

Study Officials

  • Dingqun Bai

    First Affiliated Hospital of Chongqing Medical University

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Director of rehabilitation Medicine

Study Record Dates

First Submitted

November 21, 2024

First Posted

November 26, 2024

Study Start

December 1, 2024

Primary Completion

November 1, 2025

Study Completion

December 1, 2025

Last Updated

November 26, 2024

Record last verified: 2024-11